Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9344)
All Articles published online
|
Publishing Process of This Article
|
Apr 7, 2014 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Adinolfi LE, Zampino R, Restivo L, Lonardo A, Guerrera B, Marrone A, Nascimbeni F, Florio A, Loria P. Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms. World J Gastroenterol 2014; 20(13): 3410-3417 [PMID: 24707124 DOI: 10.3748/wjg.v20.i13.3410] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v20/i13/3410.htm |
| Number | Citing Articles |
| 1 |
Hrvoje Roguljic, Vjera Nincevic, Kristina Bojanic, Lucija Kuna, Robert Smolic, Aleksandar Vcev, Dragan Primorac, Andrijana Vceva, George Y. Wu, Martina Smolic. Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.678546
|
| 2 |
Amin R. Soliman, Rabab M. Ahmed, Mahmoud Soliman, Ahmed Abdallah, Bahaa Zayed. The effect of co-infection with hepatitis B and hepatitis C viruses on the prevalence of proteinuria and loss of renal function: a single-center experience. The Egyptian Journal of Internal Medicine 2018; 30(4): 271 doi: 10.4103/ejim.ejim_51_18
|
| 3 |
Hitesh Sharma, Karen Mossman, Richard C. Austin. Fatal attractions that trigger inflammation and drive atherosclerotic disease. European Journal of Clinical Investigation 2024; 54(5) doi: 10.1111/eci.14169
|
| 4 |
Roger Bedimo, Oladapo Abodunde. Metabolic and Cardiovascular Complications in HIV/HCV-Co-infected Patients. Current HIV/AIDS Reports 2016; 13(6): 328 doi: 10.1007/s11904-016-0333-9
|
| 5 |
F. Fabrizi, R. Cerutti, F.M. Donato, P. Messa. La infección por VHB es un factor de riesgo de enfermedad renal crónica: revisión sistemática y metaanálisis. Revista Clínica Española 2021; 221(10): 600 doi: 10.1016/j.rce.2019.10.010
|
| 6 |
Luigi Adinolfi, Luca Rinaldi, Barbara Guerrera, Luciano Restivo, Aldo Marrone, Mauro Giordano, Rosa Zampino. NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. International Journal of Molecular Sciences 2016; 17(6): 803 doi: 10.3390/ijms17060803
|
| 7 |
T. Revuelto Artigas, N. Zaragoza Velasco, X. Gómez Arbones, T. Vidal Ballester, C. Piñol Felis, J.M. Reñe Espinet, A. Betriu Bars. Infección crónica por el virus de la hepatitis C: un factor de riesgo independiente para la ateromatosis subclínica. Revista Clínica Española 2019; 219(6): 293 doi: 10.1016/j.rce.2018.12.007
|
| 8 |
Luigi Elio Adinolfi, Emanuele Durante Mangoni, Aldo Marrone, Rosa Zampino, Luca Rinaldi. Liver Diseases. 2020; : 181 doi: 10.1007/978-3-030-24432-3_17
|
| 9 |
Vikash Jaiswal, Song Peng Ang, Muhammad Hanif, Mayank Jha, Vikash Kumar, Abdelmonem Siddiq, Bhavyakumar Vachhani, Anupam Halder, Michelle Koifman, Herby Jeanty, Siddharath Soni, Madeeha Subhan Waleed, Tushar Kumar, Helen Huang, Dhrubajyoti Bandyopadhyay. Cardioprotective effect of antiviral therapy among hepatitis C infected patients: A meta-analysis. IJC Heart & Vasculature 2023; 49: 101270 doi: 10.1016/j.ijcha.2023.101270
|
| 10 |
Fabrizio Fabrizi, Roberta Cerutti, Vivek Dixit, Piergiorgio Messa. The impact of antiviral therapy for HCV on kidney disease: a systematic review and meta-analysis. Nefrología 2020; 40(3): 299 doi: 10.1016/j.nefro.2019.07.007
|
| 11 |
Zobair M. Younossi, Maria Stepanova, Patrick Marcellin, Nezam Afdhal, Kris V. Kowdley, Stefan Zeuzem, Sharon L. Hunt. Treatment with ledipasvir and sofosbuvir improves patient‐reported outcomes: Results from the ION‐1, ‐2, and ‐3 clinical trials. Hepatology 2015; 61(6): 1798 doi: 10.1002/hep.27724
|
| 12 |
Jose Gabriel Solis, Ervin Saul Enciso López, Aleida Bautista Santos, Juan Carlos Anda Garay, Jose Luis Calixto Rodríguez, Rosalba Moreno Alcántar, Luis Montiel López. Effect of Antiviral Agents on Atherosclerosis in Patients with Chronic Hepatitis C. Archives of Medical Research 2021; 52(7): 764 doi: 10.1016/j.arcmed.2021.04.009
|
| 13 |
Georgios Neokosmidis, Adonis A. Protopapas, Dimitrios Stogiannou, Athanasios Filippidis, Konstantinos Tziomalos. Cardiometabolic effects of direct-acting antivirals in patients with hepatitis C. Gastroenterología y Hepatología (English Edition) 2023; 46(1): 58 doi: 10.1016/j.gastre.2022.03.008
|
| 14 |
O.O. Olubamwo, A.O. Aregbesola, J. Miettola, J. Kauhanen, T.-P. Tuomainen. Hepatitis C and risk of coronary atherosclerosis – A systematic review. Public Health 2016; 138: 12 doi: 10.1016/j.puhe.2016.04.005
|
| 15 |
Kirat Gill, Hasmik Ghazinian, Richard Manch, Robert Gish. Hepatitis C virus as a systemic disease: reaching beyond the liver. Hepatology International 2016; 10(3): 415 doi: 10.1007/s12072-015-9684-3
|
| 16 |
Qi-tao Huang, Li-lin Hang, Mei Zhong, Yun-fei Gao, Man-ling Luo, Yan-hong Yu. Maternal HCV infection is associated with intrauterine fetal growth disturbance. Medicine 2016; 95(35): e4777 doi: 10.1097/MD.0000000000004777
|
| 17 |
Roberto Minutolo, Alessio Aghemo, Antonio Chirianni, Fabrizio Fabrizi, Loreto Gesualdo, Edoardo G. Giannini, Paolo Maggi, Vincenzo Montinaro, Ernesto Paoletti, Marcello Persico, Francesco Perticone, Salvatore Petta, Massimo Puoti, Giovanni Raimondo, Maria Rendina, Anna Linda Zignego. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN). Infection 2019; 47(1): 141 doi: 10.1007/s15010-018-1209-2
|
| 18 |
Andrea TASSI, Stefano GITTO, Chiara PIRAS, Carmela CURSARO, Tatiana ALICANDRO, Marzia MARGOTTI, Marco RIVI, Pietro ANDREONE. Cognitive, neurological and psychiatric disorders occurring in Hepatitis C Virus infection. Minerva Medica 2021; 112(2) doi: 10.23736/S0026-4806.21.07388-2
|
| 19 |
Núria Esforzado, José María Morales. Hepatitis C y trasplante renal: el tiempo de la erradicación del virus ha llegado. Nefrología 2019; 39(5): 458 doi: 10.1016/j.nefro.2019.01.002
|
| 20 |
Chia‐Chi Wang, Pin‐Nan Cheng, Jia‐Horng Kao. Systematic review: chronic viral hepatitis and metabolic derangement. Alimentary Pharmacology & Therapeutics 2020; 51(2): 216 doi: 10.1111/apt.15575
|
| 21 |
Mirela Pavicic Ivelja, Ivo Ivic, Kresimir Dolic, Antonio Mestrovic, Nikola Perkovic, Stipan Jankovic, Rayaz A Malik. Evaluation of cerebrovascular reactivity in chronic hepatitis C patients using transcranial color Doppler. PLOS ONE 2019; 14(6): e0218206 doi: 10.1371/journal.pone.0218206
|
| 22 |
Mohamed A. Abd El Hafez, Zeinab Abdel Aziz Kasemy. Effect of direct-acting antivirals on platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with hepatitis C virus-related thrombocytopenia. The Egyptian Journal of Internal Medicine 2019; 31(3): 296 doi: 10.4103/ejim.ejim_14_19
|
| 23 |
Joshua S Davis, Melissa Young, Sandra Lennox, Tracey Jones, Kim Piera, Robert Pickles, Stephen Oakley. The effect of curing hepatitis C with direct-acting antiviral treatment on endothelial function. Antiviral Therapy 2018; 23(8): 687 doi: 10.3851/IMP3257
|
| 24 |
Jose M. Morales, Fabrizio Fabrizi. Hepatitis C and its impact on renal transplantation. Nature Reviews Nephrology 2015; 11(3): 172 doi: 10.1038/nrneph.2015.5
|
| 25 |
F. Fabrizi, R. Cerutti, F.M. Donato, P. Messa. HBV infection is a risk factor for chronic kidney disease: Systematic review and meta-analysis. Revista Clínica Española (English Edition) 2021; 221(10): 600 doi: 10.1016/j.rceng.2019.10.014
|
| 26 |
Olubunmi O. Olubamwo, Ifeoma N. Onyeka, Juhani Miettola, Jussi Kauhanen, Tomi‐Pekka Tuomainen. Hepatitis C as a risk factor for carotid atherosclerosis – a systematic review. Clinical Physiology and Functional Imaging 2016; 36(4): 249 doi: 10.1111/cpf.12229
|
| 27 |
Evgeniy V. Kryukov, Dmitry V. Cherkashin, Vladimir V. Saluhov, Konstantin V. Matjushenko, Aleksey D. Sobolev, Nikolaj N. Shcherbina. Extrahepatic manifestations of chronic viral hepatitis C. Bulletin of the Russian Military Medical Academy 2022; 24(2): 341 doi: 10.17816/brmma103982
|
| 28 |
Luigi Elio Adinolfi, Riccardo Nevola, Luca Rinaldi, Ciro Romano, Mauro Giordano. Chronic Hepatitis C Virus Infection and Depression. Clinics in Liver Disease 2017; 21(3): 517 doi: 10.1016/j.cld.2017.03.007
|
| 29 |
H. Husseinzadeh, T. Chiasakul, P. A. Gimotty, B. Pukenas, R. Wolf, M. Kelty, E. Chiang, P. F. Fogarty, A. Cuker. Prevalence of and risk factors for cerebral microbleeds among adult patients with haemophilia A or B. Haemophilia 2018; 24(2): 271 doi: 10.1111/hae.13398
|
| 30 |
José M. Ferro, Sofia Oliveira. Neurologic Manifestations of Gastrointestinal and Liver Diseases. Current Neurology and Neuroscience Reports 2014; 14(10) doi: 10.1007/s11910-014-0487-z
|
| 31 |
Jakob Van Herck, Jef Verbeek, Hannah van Malenstein, Wim Laleman, David Cassiman, Chris Verslype, Schalk van der Merwe, Ina Jochmans, Mauricio Sainz-Barriga, Diethard Monbaliu, Jacques Pirenne, Frederik Nevens. Liver-Related and Cardiovascular Outcome of Patients Transplanted for Nonalcoholic Fatty Liver Disease: A European Single-Center Study. Transplantation Proceedings 2021; 53(5): 1674 doi: 10.1016/j.transproceed.2021.02.025
|
| 32 |
Sha Li, Jian-Jun Li. PCSK9: A key factor modulating atherosclerosis. Journal of Atherosclerosis and Thrombosis 2015; 22(3): 221 doi: 10.5551/jat.27615
|
| 33 |
Fabrizio Fabrizi, Roberta Cerutti, Vivek Dixit, Piergiorgio Messa. The impact of antiviral therapy for HCV on kidney disease: a systematic review and meta-analysis. Nefrología (English Edition) 2020; 40(3): 299 doi: 10.1016/j.nefroe.2020.06.005
|
| 34 |
Atefe Ghamar Talepoor, Mehrnoosh Doroudchi. Immunosenescence in atherosclerosis: A role for chronic viral infections. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.945016
|
| 35 |
Luigi Elio Adinolfi, Luca Rinaldi, Riccardo Nevola. Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?. World Journal of Gastroenterology 2018; 24(41): 4617-4621 doi: 10.3748/wjg.v24.i41.4617
|
| 36 |
Shih-Yi Lin, Cheng-Li Lin, Wei-Shan Chen, Cheng-Chieh Lin, Chih-Hsueh Lin, Wu-Huei Hsu, Chung Y Hsu, Chia-Hung Kao. Association Between Alcoholic Cirrhosis and Hemorrhagic Stroke: A Nationwide Population-based Study. Alcohol and Alcoholism 2019; 54(3): 302 doi: 10.1093/alcalc/agz025
|
| 37 |
Tracey G Simon, Adeel A Butt. Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes. World Journal of Gastroenterology 2015; 21(27): 8293-8303 doi: 10.3748/wjg.v21.i27.8293
|
| 38 |
Melissa Bello-Perez, Alberto Falco, Beatriz Novoa, Luis Perez, Julio Coll, Keivan Zandi. Hydroxycholesterol binds and enhances the anti-viral activities of zebrafish monomeric c-reactive protein isoforms. PLOS ONE 2019; 14(1): e0201509 doi: 10.1371/journal.pone.0201509
|
| 39 |
T. Revuelto Artigas, N. Zaragoza Velasco, X. Gómez Arbones, T. Vidal Ballester, C. Piñol Felis, J.M. Reñe Espinet, A. Betriu Bars. Chronic hepatitis C infection: An independent risk factor for subclinical atheromatosis. Revista Clínica Española (English Edition) 2019; 219(6): 293 doi: 10.1016/j.rceng.2019.02.008
|
| 40 |
Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, Giovanni Targher, Amedeo Lonardo. Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight. International Journal of Molecular Sciences 2016; 17(3): 355 doi: 10.3390/ijms17030355
|
| 41 |
Stefano Gitto, Arrigo F.G. Cicero, Elisabetta Loggi, Marina Giovannini, Fabio Conti, Elena Grandini, Valeria Guarneri, Alessandra Scuteri, Giovanni Vitale, Carmela Cursaro, Claudio Borghi, Pietro Andreone. Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment. Annals of Hepatology 2018; 17(1): 64 doi: 10.5604/01.3001.0010.7536
|
| 42 |
|
| 43 |
Abdul-Quddus Mohammed, Ranshaka Auckle, Hai-Ling Li, Si-Ling Xu, Lu Liu, Dong-Dong Zhao, Wen-Liang Che. Pegylated Interferon-α Plus Ribavirin Therapy Improves Left Ventricular Diastolic Dysfunction in Patients With Chronic Hepatitis C Attaining Sustained Virological Response. The American Journal of the Medical Sciences 2018; 355(6): 566 doi: 10.1016/j.amjms.2018.02.001
|
| 44 |
Alejandro Alvaro-Meca, Juan Berenguer, Asunción Díaz, Dariela Micheloud, Teresa Aldámiz-Echevarría, Chiara Fanciulli, Salvador Resino, Sarah L Pett. Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era. PLOS ONE 2017; 12(6): e0179493 doi: 10.1371/journal.pone.0179493
|
| 45 |
Mohammad Said Ramadan, Filomena Boccia, Simona Maria Moretto, Fabrizio De Gregorio, Massimo Gagliardi, Domenico Iossa, Emanuele Durante-Mangoni, Rosa Zampino. Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals. Journal of Clinical Medicine 2022; 11(19): 5781 doi: 10.3390/jcm11195781
|
| 46 |
Vicente Soriano, Juan Berenguer. Extrahepatic comorbidities associated with hepatitis C virus in HIV-infected patients. Current Opinion in HIV and AIDS 2015; 10(5): 309 doi: 10.1097/COH.0000000000000175
|
| 47 |
Laith Al‐Rabadi, Terry Box, Girish Singhania, Catreena Al‐Marji, Adhish Agarwal, Isaac Hall, Craig E. Gordon, Huy Tran. Rationale for treatment of hepatitis C virus infection in end‐stage renal disease patients who are not kidney transplant candidates. Hemodialysis International 2018; 22(S1) doi: 10.1111/hdi.12656
|
| 48 |
Christopher Dächert, Evgeny Gladilin, Marco Binder. Gene Expression Profiling of Different Huh7 Variants Reveals Novel Hepatitis C Virus Host Factors. Viruses 2019; 12(1): 36 doi: 10.3390/v12010036
|
| 49 |
Maria Mazzitelli, Carlo Torti, Jolanda Sabatino, Greta Luana D’Ascoli, Chiara Costa, Vincenzo Pisani, Elena Raffetti, Salvatore De Rosa, Alessio Strazzulla, Alfredo Focà, Maria Carla Liberto, Ciro Indolfi. Evaluation of cardiac function by global longitudinal strain before and after treatment with sofosbuvir-based regimens in HCV infected patients. BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3426-9
|
| 50 |
Tomohisa Nagano, Nobuyoshi Seki, Yoichi Tomita, Tomonori Sugita, Yuta Aida, Munenori Itagaki, Satoshi Sutoh, Hiroshi Abe, Akihito Tsubota, Yoshio Aizawa. Impact of Chronic Hepatitis C Virus Genotype 1b Infection on Triglyceride Concentration in Serum Lipoprotein Fractions. International Journal of Molecular Sciences 2015; 16(9): 20576 doi: 10.3390/ijms160920576
|
| 51 |
Núria Esforzado, José María Morales. Hepatitis C and kidney transplant: The eradication time of the virus has arrived. Nefrología (English Edition) 2019; 39(5): 458 doi: 10.1016/j.nefroe.2019.01.009
|
| 52 |
Fabrizio Fabrizi, Francesca M. Donato, Piergiorgio Messa. Association Between Hepatitis B Virus and Chronic Kidney Disease: a Systematic Review and Meta-analysis. Annals of Hepatology 2017; 16(1): 21 doi: 10.5604/16652681.1226813
|
| 53 |
Steven R. Horbal, Patrick X. Belancourt, Peng Zhang, Sven A. Holcombe, Sameer Saini, Stewart C. Wang, Anne E. Sales, Grace L. Su. Independent Associations of Aortic Calcification with Cirrhosis and Liver Related Mortality in Veterans with Chronic Liver Disease. Digestive Diseases and Sciences 2024; doi: 10.1007/s10620-024-08450-5
|
| 54 |
Roberto Minutolo, Alessio Aghemo, Antonio Chirianni, Fabrizio Fabrizi, Loreto Gesualdo, Edoardo G. Giannini, Paolo Maggi, Vincenzo Montinaro, Ernesto Paoletti, Marcello Persico, Francesco Perticone, Salvatore Petta, Massimo Puoti, Giovanni Raimondo, Maria Rendina, Anna Linda Zignego. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN). Journal of Nephrology 2018; 31(5): 685 doi: 10.1007/s40620-018-0523-1
|
| 55 |
V. V. Tsvetkov, I. I. Tokin, S. A. Pozdnjakova. Clinical epidemiology of extrahepatic manifestations of chronic hepatitis C virus infection. Medical Council 2020; (21): 248 doi: 10.21518/2079-701X-2019-21-248-253
|
| 56 |
Hong-Juan Fu, Li-Bo Zhao, Ju-Jun Xue, Zhi-Xuan Wu, Yue-Ping Huang, Wei Liu, Zhan Gao. Elevated Serum Homocysteine (Hcy) Levels May Contribute to the Pathogenesis of Cerebral Infarction. Journal of Molecular Neuroscience 2015; 56(3): 553 doi: 10.1007/s12031-015-0497-6
|
| 57 |
Melissa Bello-Perez, Alberto Falco, Regla Medina-Gali, Patricia Pereiro, Jose Antonio Encinar, Beatriz Novoa, Luis Perez, Julio Coll. Neutralization of viral infectivity by zebrafish c-reactive protein isoforms. Molecular Immunology 2017; 91: 145 doi: 10.1016/j.molimm.2017.09.005
|
| 58 |
Ferdinando Carlo Sasso, Pia Clara Pafundi, Alfredo Caturano, Raffaele Galiero, Erica Vetrano, Riccardo Nevola, Salvatore Petta, Anna Ludovica Fracanzani, Carmine Coppola, Vito Di Marco, Antonio Solano, Rosa Lombardi, Mauro Giordano, Antonio Craxi, Alessandro Perrella, Celestino Sardu, Raffaele Marfella, Teresa Salvatore, Luigi Elio Adinolfi, Luca Rinaldi. Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes. Nutrition, Metabolism and Cardiovascular Diseases 2021; 31(8): 2345 doi: 10.1016/j.numecd.2021.04.016
|
| 59 |
Amedeo Lonardo, Stefano Ballestri, Giovanni Guaraldi, Fabio Nascimbeni, Dante Romagnoli, Stefano Zona, Giovanni Targher. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. World Journal of Gastroenterology 2016; 22(44): 9674-9693 doi: 10.3748/wjg.v22.i44.9674
|
| 60 |
Mauro Viganò, Massimo Colombo. Extrahepatic Manifestations of Hepatitis C Virus. Gastroenterology Clinics of North America 2015; 44(4): 775 doi: 10.1016/j.gtc.2015.07.006
|
| 61 |
Fabrizio Fabrizi, Francesca M. Donato, Piergiorgio Messa. Association Between Hepatitis C Virus and Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Annals of Hepatology 2018; 17(3): 364 doi: 10.5604/01.3001.0011.7382
|
| 62 |
Fiona Marra, Christoph Höner zu Siederdissen, Saye Khoo, David Back, Michael Schlag, Sivi Ouwerkerk‐Mahadevan, Ceyhun Bicer, Isabelle Lonjon‐Domanec, Wolfgang Jessner, Maria Beumont‐Mauviel, Ronald Kalmeijer, Markus Cornberg. Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications. British Journal of Clinical Pharmacology 2018; 84(5): 961 doi: 10.1111/bcp.13519
|
| 63 |
|
| 64 |
Juan C. Lopez-Delgado, Alessandro Putzu, Giovanni Landoni. The importance of liver function assessment before cardiac surgery: A narrative review. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.1053019
|
| 65 |
Mohamed Shengir, Mohamed Elgara, Giada Sebastiani. Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond. World Journal of Gastroenterology 2021; 27(17): 1959-1972 doi: 10.3748/wjg.v27.i17.1959
|
| 66 |
Ivan Gentile, Emanuela Zappulo, Antonio Riccardo Buonomo, Alberto Enrico Maraolo, Guglielmo Borgia. Beclabuvir for the treatment of hepatitis C. Expert Opinion on Investigational Drugs 2015; 24(8): 1111 doi: 10.1517/13543784.2015.1059820
|
| 67 |
Ciro Romano, Olga Tortorella, Liliana Dalla Mora, Dario Di Stasio, Ausilia Sellitto, Luigi Elio Adinolfi, Aldo Marrone. Prevalence and Outcome of Serum Autoantibodies in Chronic Hepatitis C Patients Undergoing Direct-Acting Antiviral Treatment. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.882064
|
| 68 |
Patrice Cacoub, Cloé Comarmond. New insights into HCV-related rheumatologic disorders: A review. Journal of Advanced Research 2017; 8(2): 89 doi: 10.1016/j.jare.2016.07.005
|
| 69 |
Fabrizio Fabrizi, Piergiorgio Messa. Managing hepatitis C therapy failures and chronic kidney disease. Expert Review of Clinical Pharmacology 2018; 11(11): 1135 doi: 10.1080/17512433.2018.1534202
|
| 70 |
Xin Su, Xin Zhao, Jia‐Long Deng, Song‐Nan Li, Xin Du, Jian‐Zeng Dong, Chang‐Sheng Ma. Antiviral treatment for hepatitis C is associated with a reduced risk of atherosclerotic cardiovascular outcomes: A systematic review and meta‐analysis. Journal of Viral Hepatitis 2021; 28(4): 664 doi: 10.1111/jvh.13469
|
| 71 |
|
| 72 |
Fanny Domont, Patrice Cacoub. Chronic hepatitis C virus infection, a new cardiovascular risk factor?. Liver International 2016; 36(5): 621 doi: 10.1111/liv.13064
|
| 73 |
M L Zubkin, V I Chervinko, Yu V Ovchinnikov, E V Kryukov, O N Kotenko. Chronic HCV infection: An internist’s opinion (Part 2). Terapevticheskii arkhiv 2016; 88(11): 138 doi: 10.17116/terarkh20168811138-148
|
| 74 |
Jing-Hua Li, Ning Zhu, Ying-Bin Min, Xiang-Zhou Shi, Yun-You Duan, Yi-Lin Yang. Ultrasonic assessment of liver stiffness and carotid artery elasticity in patients with chronic viral hepatitis. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0910-z
|
| 75 |
Salvatore Petta. Hepatitis C virus and cardiovascular: A review. Journal of Advanced Research 2017; 8(2): 161 doi: 10.1016/j.jare.2016.06.001
|
| 76 |
Hamdy A. Sliem, Ahmed S. Salem, Walid M. Hussien, Hind R.A. El Sayed. Arterial wall structural changes in noncirrhotic chronic hepatitis C patients. European Journal of Gastroenterology & Hepatology 2019; 31(11): 1432 doi: 10.1097/MEG.0000000000001429
|
| 77 |
Luca Rinaldi, Fabio Nascimbeni, Mauro Giordano, Chiara Masetti, Barbara Guerrera, Annalisa Amelia, Maria Chiara Fascione, Stefano Ballestri, Dante Romagnoli, Rosa Zampino, Riccardo Nevola, Enrica Baldelli, Natalina Iuliano, Valerio Rosato, Amedeo Lonardo, Luigi Elio Adinolfi. Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. World Journal of Gastroenterology 2017; 23(8): 1458-1468 doi: 10.3748/wjg.v23.i8.1458
|
| 78 |
Hongyi Zhou, Courtney Astore, Jeffrey Skolnick. PHEVIR: an artificial intelligence algorithm that predicts the molecular role of pathogens in complex human diseases. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-25412-x
|
| 79 |
Cristina Vassalle, Antonella Meloni, Laura Pistoia, Alessia Pepe. LIVER PANCREAS HEART TRIANGLE AND HCV IN THALASSEMIA: EXPANDING THE HORIZON THROUGH BIOMARKER NETWORKS. International Journal of Hematology and Therapy 2017; 3(1): 1 doi: 10.15436/2381-1404.17.017
|
| 80 |
Silvana Zito, Simona Mercurio, Giuseppe Mercurio, Alessandro Pigoni, Gian Mario Mandolini, Elisabetta Caletti. Neurocognitive impairment and cerebral metabolic alterations induced by direct hepatitis C virus neuroinvasion: implications on quality of life. Minerva Psichiatrica 2019; 60(2) doi: 10.23736/S0391-1772.19.02012-0
|
| 81 |
Vincent Soriano, Pablo Labarga, José V Fernandez-Montero, Carmen de Mendoza, Isabella Esposito, Laura Benítez-Gutiérrez, Pablo Barreiro. Hepatitis C Cure with Antiviral Therapy – Benefits beyond the Liver. Antiviral Therapy 2016; 21(1): 1 doi: 10.3851/IMP2975
|
| 82 |
Patrice Cacoub, Anne Claire Desbois, Cloe Comarmond, David Saadoun. Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysis. Gut 2018; 67(11): 2025 doi: 10.1136/gutjnl-2018-316234
|
| 83 |
Javier Ampuero, Manuel Romero-Gómez. Assessing cardiovascular risk in hepatitis C: An unmet need. World Journal of Hepatology 2015; 7(19): 2214-2219 doi: 10.4254/wjh.v7.i19.2214
|
| 84 |
Georgios Neokosmidis, Adonis A. Protopapas, Dimitrios Stogiannou, Athanasios Filippidis, Konstantinos Tziomalos. Cardiometabolic effects of direct-acting antivirals in patients with hepatitis C. Gastroenterología y Hepatología 2023; 46(1): 58 doi: 10.1016/j.gastrohep.2022.03.007
|
| 85 |
Patrice Cacoub, Laura Gragnani, Cloe Comarmond, Anna Linda Zignego. Extrahepatic manifestations of chronic hepatitis C virus infection. Digestive and Liver Disease 2014; 46: S165 doi: 10.1016/j.dld.2014.10.005
|
| 86 |
José M. Ferro, Pedro Viana, Patrícia Santos. Management of Neurologic Manifestations in Patients with Liver Disease. Current Treatment Options in Neurology 2016; 18(8) doi: 10.1007/s11940-016-0419-0
|
| 87 |
Hope Onohuean, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Safaa Qusti, Eida M. Alshammari, Gaber El-Saber Batiha. Covid-19 and development of heart failure: mystery and truth. Naunyn-Schmiedeberg's Archives of Pharmacology 2021; 394(10): 2013 doi: 10.1007/s00210-021-02147-6
|
| 88 |
Fabrizio Fabrizi, Francesco Negro, Mark Bondin, Patrice Cacoub. Expert Opinion on the Management of Renal Manifestations of Chronic HCV Infection. Antiviral Therapy 2018; 23(1_suppl): 57 doi: 10.3851/IMP3247
|
| 89 |
Tao Zhang, Yuan Jiang, Shuhua Zhang, Tingting Tie, Yan Cheng, Xiaoming Su, Zhu Man, Jing Hou, Li Sun, Meiyuan Tian, Yaogang Zhang, Jianhua Li, Yanyan Ma. The association between homocysteine and ischemic stroke subtypes in Chinese. Medicine 2020; 99(12): e19467 doi: 10.1097/MD.0000000000019467
|
| 90 |
Fabrizio Fabrizi, Francesca M. Donato, Piergiorgio Messa. Hepatitis C and Its Metabolic Complications in Kidney Disease. Annals of Hepatology 2017; 16(6): 851 doi: 10.5604/01.3001.0010.5275
|
| 91 |
Luigi Elio Adinolfi, Riccardo Nevola, Giacomo Lus, Luciano Restivo, Barbara Guerrera, Ciro Romano, Rosa Zampino, Luca Rinaldi, Ausilia Sellitto, Mauro Giordano, Aldo Marrone. Chronic hepatitis C virus infection and neurological and psychiatric disorders: An overview. World Journal of Gastroenterology 2015; 21(8): 2269-2280 doi: 10.3748/wjg.v21.i8.2269
|
| 92 |
Anna Linda Zignego, Manuel Ramos-Casals, Clodoveo Ferri, David Saadoun, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, Anne Claire Desbois, Cloe Comarmond, Laura Gragnani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement. Autoimmunity Reviews 2017; 16(5): 523 doi: 10.1016/j.autrev.2017.03.004
|
| 93 |
Bernard S. Kadosh, Antoinette S. Birs, Erin Flattery, Maxine Stachel, Kimberly N. Hong, Yuhe Xia, Claudia Gidea, Saima Aslam, Louai Razzouk, Tajinderpal Saraon, Randal Goldberg, Shaline Rao, Victor Pretorius, Nader Moazami, Deane E. Smith, Eric D. Adler, Alex Reyentovich. Cardiac allograft vasculopathy in heart transplant recipients from hepatitis C viremic donors. Clinical Transplantation 2024; 38(4) doi: 10.1111/ctr.15294
|
| 94 |
Sara C. LaHue, Dolores Torres, Nicole Rosendale, Vineeta Singh. Stroke Characteristics, Risk Factors, and Outcomes in Transgender Adults. The Neurologist 2019; 24(2): 66 doi: 10.1097/NRL.0000000000000226
|
| 95 |
Dante Romagnoli, Alessandra Marrazzo, Stefano Ballestri, Amedeo Lonardo, Marco Bertolotti. Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma. Journal of Clinical Virology 2015; 69: 74 doi: 10.1016/j.jcv.2015.05.023
|
| 96 |
Roberto Minutolo, Alessio Aghemo, Antonio Chirianni, Fabrizio Fabrizi, Loreto Gesualdo, Edoardo G. Giannini, Paolo Maggi, Vincenzo Montinaro, Ernesto Paoletti, Marcello Persico, Francesco Perticone, Salvatore Petta, Massimo Puoti, Giovanni Raimondo, Maria Rendina, Anna Linda Zignego. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN). Digestive and Liver Disease 2018; 50(11): 1133 doi: 10.1016/j.dld.2018.08.022
|
| 97 |
Roberto Minutolo, Alessio Aghemo, Antonio Chirianni, Fabrizio Fabrizi, Loreto Gesualdo, Edoardo G. Giannini, Paolo Maggi, Vincenzo Montinaro, Ernesto Paoletti, Marcello Persico, Francesco Perticone, Salvatore Petta, Massimo Puoti, Giovanni Raimondo, Maria Rendina, Anna Linda Zignego. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN). Internal and Emergency Medicine 2018; 13(8): 1139 doi: 10.1007/s11739-018-1940-9
|
| 98 |
Clodoveo Ferri, Manuel Ramos-Casals, Anna Linda Zignego, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, David Saadoun, Anne Claire Desbois, Marco Sebastiani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement. Autoimmunity Reviews 2016; 15(12): 1145 doi: 10.1016/j.autrev.2016.09.006
|
| 99 |
Meng-Tzu Weng, Ting-Hui Chang, Chien-Chu Lin, Chien-Sheng Wu. Rheumatic manifestations of hepatitis C virus infection are associated with autoantibodies but not viremia. Journal of Microbiology, Immunology and Infection 2023; 56(4): 739 doi: 10.1016/j.jmii.2023.03.007
|
| 100 |
Amilcar L Morales, Zachary Junga, Manish B Singla, Maria Sjogren, Dawn Torres. Hepatitis C eradication with sofosbuvir leads to significant metabolic changes. World Journal of Hepatology 2016; 8(35): 1557-1563 doi: 10.4254/wjh.v8.i35.1557
|
| 101 |
He Huang, Rongyan Kang, Zhendong Zhao, Yury E. Khudyakov. Is Hepatitis C Associated with Atherosclerotic Burden? A Systematic Review and Meta-Analysis. PLoS ONE 2014; 9(9): e106376 doi: 10.1371/journal.pone.0106376
|
| 102 |
Claudia Mascia, Miriam Lichtner, Paola Zuccalà, Serena Vita, Tiziana Tieghi, Raffaella Marocco, Stefano Savinelli, Raffaella Rossi, Marco Iannetta, Michela Campagna, Francesco Schiavone, Fabio Mengoni, Gianluca Russo, Claudio Maria Mastroianni, Vincenzo Vullo. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection. Clinics and Research in Hepatology and Gastroenterology 2017; 41(6): 644 doi: 10.1016/j.clinre.2017.04.007
|
| 103 |
Michael Broker, Shalom Z. Frager, Nayan S. Patel, Edward Lebovics, William H. Frishman. The Inflammatory Relationship Between Hepatitis C Virus With Coronary and Carotid Atherosclerosis. Cardiology in Review 2021; 29(4): 178 doi: 10.1097/CRD.0000000000000314
|
| 104 |
Maria Perticone, Raffaele Maio, Eliezer Joseph Tassone, Giovanni Tripepi, Serena Di Cello, Sofia Miceli, Benedetto Caroleo, Angela Sciacqua, Anna Licata, Giorgio Sesti, Francesco Perticone. Insulin-resistance HCV infection-related affects vascular stiffness in normotensives. Atherosclerosis 2015; 238(1): 108 doi: 10.1016/j.atherosclerosis.2014.11.025
|
| 105 |
Giovanni Targher, Christopher D. Byrne. Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. Nature Reviews Nephrology 2017; 13(5): 297 doi: 10.1038/nrneph.2017.16
|
| 106 |
Fernando Scudiero, Renato Valenti, Rossella Marcucci, Giuseppe D. Sanna, Anna Maria Gori, Angela Migliorini, Raffaele Vitale, Betti Giusti, Elena De Vito, Giulia Corda, Rita Paniccia, Davide Zirolia, Mario E. Canonico, Guido Parodi. Platelet Reactivity in Hepatitis C Virus–Infected Patients on Dual Antiplatelet Therapy for Acute Coronary Syndrome. Journal of the American Heart Association 2020; 9(18) doi: 10.1161/JAHA.120.016441
|
| 107 |
Ciro Romano, Giovanna Cuomo, Roberta Ferrara, Andrea Del Mastro, Sergio Esposito, Ausilia Sellitto, Luigi Elio Adinolfi. Uncommon immune-mediated extrahepatic manifestations of HCV infection. Expert Review of Clinical Immunology 2018; 14(12): 1089 doi: 10.1080/1744666X.2018.1538790
|
| 108 |
Theodoros Voulgaris, Vassilios A. Sevastianos. Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C Virus. Hepatitis Research and Treatment 2016; 2016: 1 doi: 10.1155/2016/7629318
|
| 109 |
Kristine S. Alexander, Neil A. Zakai, Steven D. Lidofsky, Peter W. Callas, Suzanne E. Judd, Russell P. Tracy, Mary Cushman, Pavel Strnad. Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort. PLOS ONE 2018; 13(3): e0194153 doi: 10.1371/journal.pone.0194153
|
| 110 |
Patrice Cacoub, Pierre Nahon, Richard Layese, Lorraine Blaise, Anne Claire Desbois, Valérie Bourcier, Carole Cagnot, Patrick Marcellin, Dominique Guyader, Stanislas Pol, Dominique Larrey, Victor De Lédinghen, Denis Ouzan, Fabien Zoulim, Dominique Roulot, Albert Tran, Jean-Pierre Bronowicki, Jean-Pierre Zarski, Ghassan Riachi, Paul Calès, Jean-Marie Péron, Laurent Alric, Marc Bourlière, Philippe Mathurin, Jean-Frédéric Blanc, Armand Abergel, Lawrence Serfaty, Ariane Mallat, Jean-Didier Grangé, Pierre Attali, Yannick Bacq, Claire Wartelle, Thông Dao, Dominique Thabut, Christophe Pilette, Christine Silvain, Christos Christidis, Dominique Capron, Gérard Thiefin, David Zucman, Vincent Di Martino, Corinne Isnard Bagnis, Marianne Ziol, Angela Sutton, Eric Letouze, Françoise Roudot-Thoraval, Etienne Audureau, Pierre Nahon, Patrick Marcellin, Dominique Guyader, Stanislas Pol, Hélène Fontaine, Dominique Larrey, Victor De Lédinghen, Denis Ouzan, Fabien Zoulim, Dominique Roulot, Albert Tran, Jean-Pierre Bronowicki, Jean-Pierre Zarski, Vincent Leroy, Ghassan Riachi, Paul Calès, Jean-Marie Péron, Laurent Alric, Marc Bourlière, Philippe Mathurin, Sebastien Dharancy, Jean-Frédéric Blanc, Armand Abergel, Lawrence Serfaty, Ariane Mallat, Jean-Didier Grangé, Pierre Attali, Yannick Bacq, Claire Wartelle, Thông Dao, Yves Benhamou, Christophe Pilette, Christine Silvain, Christos Christidis, Dominique Capron, Gérard Thiefin, Sophie Hillaire, Vincent Di Martino. Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients. American Heart Journal 2018; 198: 4 doi: 10.1016/j.ahj.2017.10.024
|
| 111 |
Timothy C Durazzo, Linh-Chi Nguyen, Dieter J Meyerhoff. Medical Conditions Linked to Atherosclerosis Are Associated With Magnified Cortical Thinning in Individuals With Alcohol Use Disorders. Alcohol and Alcoholism 2020; 55(4): 382 doi: 10.1093/alcalc/agaa034
|
| 112 |
Shilu Mathew, Muhammed Faheem, Sara M Ibrahim, Waqas Iqbal, Bisma Rauff, Kaneez Fatima, Ishtiaq Qadri. Hepatitis C virus and neurological damage. World Journal of Hepatology 2016; 8(12): 545-556 doi: 10.4254/wjh.v8.i12.545
|
| 113 |
Patrice Cacoub, Cloe Comarmond, Fanny Domont, Léa Savey, Anne C. Desbois, David Saadoun. Extrahepatic manifestations of chronic hepatitis C virus infection. Therapeutic Advances in Infectious Disease 2016; 3(1): 3 doi: 10.1177/2049936115585942
|
| 114 |
Alex Reyentovich, Claudia G. Gidea, Deane Smith, Bonnie Lonze, Zachary Kon, Anthony Fargnoli, Jennifer Pavone, Shaline Rao, Tajinderpal Saraon, Tyler Lewis, Yingzhi Qian, Ira Jacobson, Nader Moazami. Outcomes of the Treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donors. Clinical Transplantation 2020; 34(9) doi: 10.1111/ctr.13989
|
| 115 |
Javier Pagan, Marco Ladino, David Roth. Treating hepatitis C virus in dialysis patients: How, when, and why?. Seminars in Dialysis 2019; 32(2): 152 doi: 10.1111/sdi.12764
|
| 116 |
Arpan Mohanty, Sarah Salameh, Adeel A. Butt. Impact of Direct Acting Antiviral Agent Therapy upon Extrahepatic Manifestations of Hepatitis C Virus Infection. Current HIV/AIDS Reports 2019; 16(5): 389 doi: 10.1007/s11904-019-00466-1
|
| 117 |
Ming V. Lin, Meghan E. Sise, Martha Pavlakis, Beth M. Amundsen, Donald Chute, Anna E. Rutherford, Raymond T. Chung, Michael P. Curry, Jasmine M. Hanifi, Steve Gabardi, Anil Chandraker, Eliot C. Heher, Nahel Elias, Leonardo V. Riella, Chen-Hua Liu. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection. PLOS ONE 2016; 11(7): e0158431 doi: 10.1371/journal.pone.0158431
|
| 118 |
Maria M. Xu, Patrick A. Murphy, Anthony T. Vella. Activated T-effector seeds: cultivating atherosclerotic plaque through alternative activation. American Journal of Physiology-Heart and Circulatory Physiology 2019; 316(6): H1354 doi: 10.1152/ajpheart.00148.2019
|
| 119 |
Simona Cammarota, Anna Citarella, Antonella Guida, Valeria Conti, Teresa Iannaccone, Maria Elena Flacco, Francesca Bravi, Cristina Naccarato, Antonella Piscitelli, Raffaele Piscitelli, Alfredo Valente, Giulio Calella, Nicola Coppola, Giustino Parruti, Yury E Khudyakov. The inpatient hospital burden of comorbidities in HCV-infected patients: A population-based study in two Italian regions with high HCV endemicity (The BaCH study). PLOS ONE 2019; 14(7): e0219396 doi: 10.1371/journal.pone.0219396
|
| 120 |
Andrea Pascual-Oliver, Diego Casas-Deza, Carmen Yagüe-Caballero, Jose M. Arbones-Mainar, Vanesa Bernal-Monterde. Lipid Profile and Cardiovascular Risk Modification after Hepatitis C Virus Eradication. Pathogens 2024; 13(4): 278 doi: 10.3390/pathogens13040278
|
| 121 |
Juan Berenguer, Elena Rodríguez‐Castellano, Ana Carrero, Miguel A. Von Wichmann, Marta Montero, María J. Galindo, Josep Mallolas, Manuel Crespo, María J. Téllez, Carmen Quereda, José Sanz, Carlos Barros, Cristina Tural, Ignacio Santos, Federico Pulido, Josep M. Guardiola, Rafael Rubio, Enrique Ortega, María L. Montes, Juan J. Jusdado, Gabriel Gaspar, Herminia Esteban, José M. Bellón, Juan González‐García. Eradication of hepatitis C virus and non‐liver‐related non–acquired immune deficiency syndrome–related events in human immunodeficiency virus/hepatitis C virus coinfection. Hepatology 2017; 66(2): 344 doi: 10.1002/hep.29071
|
| 122 |
Ming-Shyan Lin, Chang-Min Chung, Wey-Yil Lin, Kuo-Liang Wei, Jui Wang, Ying-Ying Lee, Jing-Hong Hu, Tao-Hsin Tung, Yu-Sheng Lin. Antiviral Therapy Reduces Risk of Haemorrhagic Stroke in Patients with HCV Infection: A Nationwide Cohort Study. Antiviral Therapy 2018; 23(1): 43 doi: 10.3851/IMP3172
|
| 123 |
Kazuhiro Osawa, Toru Miyoshi, Kentarou Yamauchi, Yasushi Koyama, Kazufumi Nakamura, Shuhei Sato, Susumu Kanazawa, Hiroshi Ito, Giovanni Targher. Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT. PLOS ONE 2015; 10(6): e0131138 doi: 10.1371/journal.pone.0131138
|
| 124 |
|
| 125 |
Annalisa Cespiati, Inês Coelho Rodrigues, Inês Santos, Sara Policarpo, Sofia Carvalhana, Anna Ludovica Fracanzani, Helena Cortez‐Pinto. Effect of HCV eradication by DAAs on liver steatosis, carotid atherosclerosis, and associated metabolic comorbidities: A systematic review. Liver International 2024; 44(5): 1075 doi: 10.1111/liv.15876
|
| 126 |
Patrice Cacoub, Cloé Comarmond. Considering hepatitis C virus infection as a systemic disease. Seminars in Dialysis 2019; 32(2): 99 doi: 10.1111/sdi.12758
|
| 127 |
Dalia A Freekh, Maged W Helmy, Mohamed Said, Noha M El-khodary. The effect of direct acting antiviral agents on vascular endothelial function in Egyptian patients with chronic hepatitis C virus infection. Saudi Pharmaceutical Journal 2021; 29(10): 1120 doi: 10.1016/j.jsps.2021.08.006
|